Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trail-Reference-Cited by-同舟云学术

Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trail

Published:2013-11 Issue:2 Volume:109 Page:275-280
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Meng Xue,Wang Jianhua,Sun Xindong,Wang Lvhua,Ye Ming,Feng Pingbo,Zhu Guangying,Lu You,Han Chun,Zhu Shuchai,Liao Zhongxing,Yu Jinming

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference17 articles.

1. A phase I trail of definitive chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trail (KDOG 0501);Higuchi;Radiother Oncol,2008

2. Current developments in the management of locally advanced esophageal cancer;McNamara;Curr Oncol Rep,2012

3. Radiochemotherapy of esophageal cancer;Liao;J Thorac Oncol,2007

4. Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study;Moehler;Ann Oncol,2011

5. Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro;Zhang;Radiother Oncol,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Meta-Analysis and Review of Radiation Dose Escalation in Definitive Radiation Therapy between Squamous Cell Carcinoma and Adenocarcinoma of Esophageal Cancer;Cancers;2024-02-03

2. Toward Targeted Therapies in Oesophageal Cancers: An Overview;Cancers;2022-03-16

3. Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma;Cancer Biology & Medicine;2022-01-12

4. Advances in the pharmacotherapeutic management of esophageal squamous cell carcinoma;Expert Opinion on Pharmacotherapy;2020-10-09

5. A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy;Therapeutic Advances in Medical Oncology;2020-01